Endologix (ELGX) Posts Q4 Loss of $0.26/Share; Reaffirms FY19 Revenue Forecast
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Endologix (ELGX) PT Lowered to $1.50 at RBC Capital
February 26, 2019 6:28 AM ESTRBC Capital analyst Glenn Novarro lowered the price target on Endologix (NASDAQ: ELGX) to $1.50 (from $2.00) while maintaining a Sector Perform rating.
The analyst notes 4Q18 revenues and 2019 guidance in line with preannouncement.
... More


